Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-05-23 @ 1:10 PM
Study NCT ID:
NCT03067935
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2018-05-21
First Post:
2017-02-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Individual Patient Expanded Access-Glembatumumab Vedotin
Sponsor:
Celldex Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic gpNMB Expressing Triple Negative Breast Cancer | View |
Keywords: